Week 4 and the Scale Hasn't Moved
Four weeks in, side effects show up before results often do. Here is why early weeks on a GLP-1 frequently look flat — and why that does not predict your outcome.
You started a GLP-1 four weeks ago hoping for the dramatic before-and-after you have seen online. Instead you have had some nausea, maybe constipation, and the scale looks roughly the same. The disappointment is real. So is the temptation to assume it is not working.
Before you draw conclusions, look at the trial design. Both major GLP-1 trials — STEP 1 for semaglutide and SURMOUNT-1 for tirzepatide — used a careful four to five month titration where doses start low and step up slowly. The first month is mostly about your body learning to tolerate the medication, not about hitting your target dose. Most people do not see meaningful weight loss in weeks 1–4 because they are not yet on a weight-loss dose.
This guide explains what week 4 usually looks like, why it is normal, and the small set of red flags that justify an early call to your provider.
Is this normal?
Yes — very. The starting dose of semaglutide is 0.25 mg weekly, and the starting dose of tirzepatide is 2.5 mg weekly. Both are explicitly described in their labels as initiation doses, not treatment doses. They exist to let your gut adapt before you climb to a dose that meaningfully suppresses appetite and drives weight loss.
In STEP 1, the full maintenance dose of semaglutide (2.4 mg) was not reached until week 16. In SURMOUNT-1, the highest tirzepatide doses (10 mg, 12.5 mg, and 15 mg) were not reached until weeks 20 to 24. Average weight loss curves from both trials are nearly flat for the first month and only start to clearly diverge from placebo around weeks 6 to 8.
A few pounds either way at week 4 — gain or loss — is normal variation. Salt intake, fluid balance, menstrual cycle, sleep, and bowel patterns all move the scale more than a starting GLP-1 dose does. The fact that it has not moved is almost never a sign the medication will not work.
Why this happens
What month 1 actually does
Starting dose is sub-therapeutic
0.25 mg semaglutide and 2.5 mg tirzepatide exist mostly to acclimate your gut. They produce some appetite effect but rarely meaningful weight loss.
Drug levels are still building
Both semaglutide and tirzepatide have long half-lives. It takes roughly 4 to 5 weeks of weekly dosing to approach steady-state blood levels.
Water shifts can hide loss
Lower carbohydrate intake or constipation early on can cause water and bowel-content shifts that mask real fat loss on the scale.
Daily weight is noisy
Body weight varies by 2 to 5 pounds across a normal day. A flat reading at week 4 reflects measurement noise as much as physiology.
What you can do this week
Stay the course. The biggest mistake at week 4 is changing the plan before it has had a chance to work. Keep your appointment for the next titration step, assuming you are tolerating the current dose well enough.
Use the time well. Build the habits now that will determine outcomes in months 3 through 9: get protein at every meal (aim for at least 30 grams at breakfast), drink water before meals, walk after meals, and start two short resistance training sessions a week. People who build these habits in month 1 lose more weight overall — even though the scale shows it later.
Track waist and how clothes fit, not just the scale. In the first 4 to 8 weeks, body composition can shift before total weight does. A waist that is half an inch smaller with the same scale number is real progress.
If side effects are limiting your ability to eat, focus on getting through them rather than on the scale. Bland foods, slow eating, hydration, and time are usually enough.
When to talk to your provider
Common Concerns
Is no weight loss at week 4 a reason to stop the medication?expand_more
Should my doctor increase the dose now?expand_more
What if I have gained weight at week 4?expand_more
When should I expect real weight loss?expand_more
Keep exploring
Browse all GLP-1 guides or read about dosing schedules.